Quantitation of thrombin-activatable fibrinolysis inhibitor in human plasma by isotope dilution mass spectrometry – Analytical Biochemistry, 2022
Candidate High-Resolution Mass Spectrometry-Based Reference Method for the Quantification of Procalcitonin in Human Serum Using a Characterized Recombinant Protein as a Primary Calibrator – Analytical Chemistry, 94(10), 4146‑4154.. 2022
A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease – Brain Communications, 4(2). 2022
Accelerating the Validation of Endogenous On-Target Engagement and <em>In-cellulo</em> Kinetic Assessment for Covalent Inhibitors of KRAS G12C in Early Drug Discovery – bioRxiv. 2022
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans – Clinical Pharmacology & ; Therapeutics, 109(6), 1575‑1582. 2021
Development of immunoprecipitation – two-dimensional liquid chromatography – mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients – Journal of Chromatography A, 1651, 462299. 2021
A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM) – Clinical Cancer Research, 27(18), 5028‑5037. 2021
Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M-Protein in the Blood of Multiple Myeloma Patients – Journal of Proteome Research, 20(8), 4176‑4185. 2021
A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM) – Clinical Cancer Research, 27(18), 5028‑5037. 2021
Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry – Therapeutic Drug Monitoring: April 04, 2019
Direct quantitation of therapeutic antibodies for pharmacokinetic studies using immuno-purification and intact mass analysis – Bioanalysis. 2019: Vol 3 No3
7, parvis Louis Néel • BHT 52 A • CS 20050
38040 Grenoble Cedex 9 • FRANCE
PHONE: +33 4 38 02 36 50